Amgen appoints Matthew C. Busch as new Chief Accounting Officer effective Aug 14, 2023

AMGEN INC

Matthew C. Busch, 49, named VP, Finance and CAO; succeeds Linda H. Louie who moves to VP, Finance.
Busch's annual base salary set at $450,000; bonus target 40% of salary; long-term equity award $500,000.
Busch has held various finance roles at Amgen since 2004, most recently VP, Finance since 2021.
No employment agreement or family relationships with other officers or directors disclosed.
Transition part of leadership development; Louie will lead corporate financial planning and analysis.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Matthew C. Busch

Vice President, Finance and Chief Accounting Officer

AMGN · AMGEN INC

Effective: 2023-08-14
Filed: August 4, 2023, 7:59 PM ET

On August 1, 2023, the Board of Directors (the “Board”) of Amgen Inc. (the “Company”) appointed Matthew C. Busch, age 49, to serve as the Company’s Vice President, Finance and Chief Accounting Officer (“CAO”), effective August 14, 2023.

Role change

Linda H. Louie

Vice President, Finance

AMGN · AMGEN INC

Effective: 2023-08-14
Successor: Matthew C. Busch
Filed: August 4, 2023, 7:59 PM ET

Linda H. Louie, the Company’s current CAO, has served in this role since July 2020, and effective August 14, 2023, as part of the Company’s leadership development activities, Ms. Louie will move to the role of the Company’s Vice President, Finance, with responsibility for corporate financial planning and analysis, and will step down as the Company’s Chief Accounting Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Matthew C. Busch was appointed as Vice President, Finance and Chief Accounting Officer at AMGEN INC.

Action: appointed
Role: Vice President, Finance and Chief Accounting Officer

Exact text from the filing

On August 1, 2023, the Board of Directors (the “Board”) of Amgen Inc. (the “Company”) appointed Matthew C. Busch, age 49, to serve as the Company’s Vice President, Finance and Chief Accounting Officer (“CAO”), effective August 14, 2023.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Linda H. Louie changed role as Vice President, Finance at AMGEN INC.

Action: transitioned
Role: Vice President, Finance

Exact text from the filing

Linda H. Louie, the Company’s current CAO, has served in this role since July 2020, and effective August 14, 2023, as part of the Company’s leadership development activities, Ms. Louie will move to the role of the Company’s Vice President, Finance, with responsibility for corporate financial planning and analysis, and will step down as the Company’s Chief Accounting Officer.

View on SEC.gov

AMGEN INC filing history →

Source: SEC EDGAR

accession 0001193125-23-203033

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.